The Australian High Court has handed down a highly anticipated decision on the validity of Myriad Genetics’ patent claims for isolated gene sequences, including mutations in the BRCA1 gene
1 Dec
2015
The Australian High Court has handed down a highly anticipated decision on the validity of Myriad Genetics’ patent claims for isolated gene sequences, including mutations in the BRCA1 gene
